FDA Inspection 1223217 — Reproductive Resources Inc.
The FDA completed an inspection of Reproductive Resources Inc. on November 14, 2023 in Metairie, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 14, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Metairie, LA (United States)